Variant report
| Variant | esv33798 |
|---|---|
| Chromosome Location | chr5:179075713-179078250 |
| allele | n/a |
| Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:61)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
| No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
|---|---|---|---|---|---|---|
| 1 | BHLHE40 | chr5:179075535-179075759 | HepG2 | liver: | n/a | n/a |
| 2 | BHLHE40 | chr5:179075505-179075756 | K562 | blood: | n/a | n/a |
| 3 | CTCF | chr5:179076103-179076173 | Spleen_OC | spleen: | n/a | n/a |
| 4 | CTCF | chr5:179078140-179078290 | NHDF-neo | bronchial: | n/a | chr5:179078192-179078210 |
| 5 | E2F6 | chr5:179076683-179076795 | K562 | blood: | n/a | n/a |
| 6 | ELF1 | chr5:179076235-179076491 | K562 | blood: | n/a | chr5:179076372-179076385 |
| 7 | FOXA1 | chr5:179075948-179076171 | HepG2 | liver: | n/a | chr5:179076077-179076089 |
| 8 | MAX | chr5:179075469-179075831 | K562 | blood: | n/a | chr5:179075657-179075668 chr5:179075657-179075667 chr5:179075658-179075667 chr5:179075657-179075668 chr5:179075656-179075669 chr5:179075656-179075671 |
| 9 | MAX | chr5:179075543-179075763 | K562 | blood: | n/a | chr5:179075657-179075668 chr5:179075657-179075667 chr5:179075658-179075667 chr5:179075657-179075668 chr5:179075656-179075669 chr5:179075656-179075671 |
| 10 | NR2F2 | chr5:179076883-179077240 | K562 | blood: | n/a | n/a |
| 11 | NR2F2 | chr5:179076801-179077180 | K562 | blood: | n/a | n/a |
| 12 | PBX3 | chr5:179075898-179076022 | GM12878 | blood: | n/a | chr5:179075989-179075998 |
| 13 | POLR2A | chr5:179075354-179076708 | K562 | blood: | n/a | n/a |
| 14 | USF1 | chr5:179075560-179075762 | K562 | blood: | n/a | n/a |
| No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
|---|---|---|---|---|
| 1 | chr5:179075765-179075815 | SK-N-SH_RA | brain: | n/a |
| 2 | chr5:179075765-179075815 | SK-N-MC | brain: | n/a |
| 3 | chr5:179075765-179075815 | HAEpiC | amniotic membrane: | n/a |
| 4 | chr5:179075765-179075815 | NHDF-neo | bronchial: | n/a |
| 5 | chr5:179075765-179075815 | U87 | brain: | n/a |
| 6 | chr5:179075765-179075815 | PrEC | prostate: | n/a |
| 7 | chr5:179075765-179075815 | MCF10A-Er-Src | breast: | n/a |
| 8 | chr5:179075765-179075815 | BJ | skin: | n/a |
| 9 | chr5:179075765-179075815 | H1-hESC | embryonic stem cell: | embryo |
| 10 | chr5:179075765-179075815 | NT2-D1 | testis: | n/a |
| 11 | chr5:179075765-179075815 | GM12891 | blood: | n/a |
| 12 | chr5:179075765-179075815 | ovcar-3 | ovarian: | n/a |
| 13 | chr5:179075765-179075815 | IMR90 | lung: | fetal |
| 14 | chr5:179075765-179075815 | NHBE | bronchial: | n/a |
| 15 | chr5:179075765-179075815 | HRE | kidney: | n/a |
| 16 | chr5:179075765-179075815 | HEK293 | kidney: | embryo |
| 17 | chr5:179075765-179075815 | HCT-116 | colon: | n/a |
| 18 | chr5:179075765-179075815 | HRCEpiC | kidney: | n/a |
| 19 | chr5:179075765-179075815 | ECC-1 | luminal epithelium: | n/a |
| 20 | chr5:179075765-179075815 | HUVEC | blood vessel: | n/a |
| 21 | chr5:179075765-179075815 | SK-N-SH | brain: | n/a |
| 22 | chr5:179075765-179075815 | GM19239 | blood: | n/a |
| 23 | chr5:179075765-179075815 | Hela-S3 | cervix: | n/a |
| 24 | chr5:179075765-179075815 | HPAEpiC | pulmonary alveolar: | n/a |
| 25 | chr5:179075765-179075815 | HCF | heart: | n/a |
| 26 | chr5:179075765-179075815 | HL-60 | blood: | n/a |
| 27 | chr5:179075765-179075815 | LNCaP | prostate: | n/a |
| 28 | chr5:179075765-179075815 | Jurkat | blood: | n/a |
| 29 | chr5:179075765-179075815 | HMEC | breast: | n/a |
| 30 | chr5:179075765-179075815 | HNPCEpiC | eye: | n/a |
| 31 | chr5:179075765-179075815 | PANC-1 | pancreas: | n/a |
| 32 | chr5:179075765-179075815 | AG09319 | gingival: | n/a |
| 33 | chr5:179075765-179075815 | Caco-2 | colon: | n/a |
| 34 | chr5:179075765-179075815 | SKMC | muscle: | n/a |
| 35 | chr5:179075765-179075815 | ProgFib | skin: | n/a |
| 36 | chr5:179075765-179075815 | NB4 | blood: | n/a |
| 37 | chr5:179075765-179075815 | HepG2 | liver: | n/a |
| 38 | chr5:179075765-179075815 | GM12892 | blood: | n/a |
| 39 | chr5:179075765-179075815 | HIPEpiC | eye: | n/a |
| 40 | chr5:179075765-179075815 | GM06990 | blood: | n/a |
| 41 | chr5:179075765-179075815 | A549 | lung: | n/a |
| 42 | chr5:179075765-179075815 | MCF-7 | breast: | n/a |
| 43 | chr5:179075765-179075815 | HEEpiC | esophagus: | n/a |
| 44 | chr5:179075765-179075815 | AG10803 | skin: | n/a |
| 45 | chr5:179075765-179075815 | T-47D | breast: | n/a |
| 46 | chr5:179075765-179075815 | NH-A | brain: | n/a |
| 47 | chr5:179075765-179075815 | HRPEpiC | eye: | n/a |
| 48 | chr5:179075765-179075815 | AoSMC | blood vessel: | n/a |
| 49 | chr5:179075765-179075815 | HCM | heart: | n/a |
| 50 | chr5:179075765-179075815 | CMK | blood: | n/a |
(count:4 , 50 per page) page:
1
| No. | Distal block | Cell Line | Cell type | Cell Stage |
|---|---|---|---|---|
| 1 | chr5:179049010..179052109-chr5:179075423..179078137,6 | MCF-7 | breast: | |
| 2 | chr5:178976725..178979261-chr5:179073948..179076733,2 | MCF-7 | breast: | |
| 3 | chr5:179049252..179051807-chr5:179078099..179079783,3 | MCF-7 | breast: | |
| 4 | chr5:179048380..179051829-chr5:179074872..179077735,3 | K562 | blood: |
| No data |
| No data |
| No data |
| Variant related genes | Relation type |
|---|---|
| C5orf60 | TF binding region |
| ENSG00000228259 | TF binding region |
| C5orf60 | CpG island |
| ENSG00000228259 | CpG island |
| ENSG00000176783 | chromatin interactions |
| ENSG00000169045 | chromatin interactions |
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs538300611 | chr5:179075729-179075730 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 2 | rs552054424 | chr5:179075741-179075742 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 3 | rs371860528 | chr5:179075748-179075749 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 4 | rs75784797 | chr5:179075759-179075760 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 5 | rs534508224 | chr5:179075765-179075766 | Weak transcription Enhancers | TF binding regionCpG islandChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 6 | rs574179682 | chr5:179075822-179075823 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 7 | rs536992342 | chr5:179075837-179075838 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 8 | rs191507839 | chr5:179075850-179075851 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 9 | rs112392392 | chr5:179075877-179075878 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 10 | rs4343806 | chr5:179075908-179075909 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
| 11 | rs67811339 | chr5:179075916-179075917 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 12 | rs398093922 | chr5:179075919-179075920 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 13 | rs113789371 | chr5:179075934-179075935 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 14 | rs545006525 | chr5:179075947-179075948 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 15 | rs563202924 | chr5:179075956-179075957 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 16 | rs575185444 | chr5:179075962-179075963 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 17 | rs185663375 | chr5:179075969-179075970 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 18 | rs542387757 | chr5:179075988-179075989 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 19 | rs10039578 | chr5:179075989-179075990 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
| 20 | rs368405192 | chr5:179075993-179075994 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 21 | rs528313548 | chr5:179076000-179076001 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 22 | rs371795841 | chr5:179076004-179076005 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 23 | rs546669781 | chr5:179076018-179076019 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 24 | rs564830378 | chr5:179076077-179076078 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 25 | rs556643205 | chr5:179076087-179076088 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 26 | rs73809617 | chr5:179076219-179076220 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
| 27 | rs550609333 | chr5:179076239-179076240 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 28 | rs73809619 | chr5:179076302-179076303 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 29 | rs114407468 | chr5:179076372-179076373 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 30 | rs549733063 | chr5:179076377-179076378 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 31 | rs567838728 | chr5:179076468-179076469 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 32 | rs75223726 | chr5:179076495-179076496 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 33 | rs181620733 | chr5:179076500-179076501 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 34 | rs553386468 | chr5:179076505-179076506 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 35 | rs571662112 | chr5:179076561-179076562 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 36 | rs144559137 | chr5:179076574-179076575 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 37 | rs556960459 | chr5:179076592-179076593 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 38 | rs372835599 | chr5:179076597-179076598 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 39 | rs559416019 | chr5:179076609-179076610 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 40 | rs542501901 | chr5:179076623-179076624 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 41 | rs185571824 | chr5:179076635-179076636 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 42 | rs545595085 | chr5:179076663-179076664 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 43 | rs572945263 | chr5:179076691-179076692 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 44 | rs566099060 | chr5:179076699-179076700 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 45 | rs540062351 | chr5:179076711-179076712 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 46 | rs564957203 | chr5:179076712-179076713 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
| 47 | rs532275199 | chr5:179076738-179076739 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
| 48 | rs367823175 | chr5:179076741-179076742 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
| 49 | rs544345913 | chr5:179076757-179076758 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
| 50 | rs73336072 | chr5:179076759-179076760 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
| Disease | PMID | Source |
|---|---|---|
| Ewing''s sarcoma | 21437220 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Acute lymphoblastic leukemia | 17690704 | CNVD |
| Gastrointestinal stromal cancer | 16982739 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Phyllodes tumor | 17334353 | CNVD |
| Malaria | 21533027 | CNVD |
| Renal cell carcinoma | 19461508 | CNVD |
| Cancer | 20164919 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Cancer | 16751803 | CNVD |
| Acute lymphoblastic leukemia | 20067559 | CNVD |
| Glioma | 20126413 | CNVD |
| Cancer | 22429812 | CNVD |
| Cancer | 21637783 | CNVD |
| Colorectal cancer | 20709793 | CNVD |
| Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
| Liposarcoma | 21253554 | CNVD |
| Acute lymphoblastic leukemia | 21390130 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Esophageal squamous carcinoma | 21637470 | CNVD |
| Glioblastoma multiforme | 19960244 | CNVD |
| Glioblastoma multiforme | 17387387 | CNVD |
| Leukemia | 17361228 | CNVD |
| Myelodysplastic syndrome | 18508791 | CNVD |
| 5q-syndrome | 17576883 | CNVD |
| Gastric cancer | 17908304 | CNVD |
| Lung cancer | 16740712 | CNVD |
| Oral squamous cell carcinoma | 17134496 | CNVD |
| Urothelial carcinoma | 21177765 | CNVD |
| Esophageal adenocarcinoma | 19417022 | CNVD |
| Barrett''s syndrome | 19417022 | CNVD |
| Thyroid cancer | 19087340 | CNVD |
| Acute myeloid leukemia | 20729466 | CNVD |
| lymphocytic leukemia | 21291569 | CNVD |
| Multiple myeloma | 17550852 | CNVD |
| Salivary gland tumor | 18059337 | CNVD |
| Renal cell carcinoma | 19377443 | CNVD |
| Lung cancer | 18438408 | CNVD |
| Gastrointestinal stromal cancer | 19259404 | CNVD |
| Renal cell carcinoma | 18592004 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| Breast cancer | 20668451 | CNVD |
| Cancer | 20668451 | CNVD |
| Lung cancer | 20668451 | CNVD |
| Ovarian cancer | 20668451 | CNVD |
| Pancreas cancer | 20668451 | CNVD |
| Prostate cancer | 20668451 | CNVD |
| Myofibroblastic sarcoma | 19369631 | CNVD |
| Embryonal rhabdomyosarcoma | 16790082 | CNVD |
| Biliary cancer | 20360734 | CNVD |
| Breast cancer | 20360734 | CNVD |
| Coronary artery disease | 20360734 | CNVD |
| Crohn''s disease | 20360734 | CNVD |
| Hypertension | 20360734 | CNVD |
| Rheumatoid arthritis | 20360734 | CNVD |
| Type 1 diabetes | 20360734 | CNVD |
| Type 2 diabetes | 20360734 | CNVD |
| Prostate cancer | 18632612 | CNVD |
| epilepsy | 18472482 | CNVD |
| Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
| Sotos syndrome | 21572526 | CNVD |
| T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
| Sotos syndrome | 17561922 | CNVD |
| Sotos syndrome | 16773131 | CNVD |
| Mental retardation | 16773131 | CNVD |
| Sotos syndrome | 22470819 | CNVD |
| Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
| Acute myeloid leukemia | 18000384 | CNVD |
| Sudden cardiac death | 19188705 | CNVD |
| Basal cell lymphoma | 16317097 | CNVD |
| Chordoma | 18071362 | CNVD |
| Diffuse large b-cell lymphoma | 16317097 | CNVD |
| Olfactory neuroblastoma | 18408657 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| abnormal development | 18461090 | CNVD |
| T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
| Lung cancer | 17297452 | CNVD |
| Cancer | 20164920 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| Breast cancer | 21509527 | CNVD |
| Breast cancer | 21804112 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Sotos syndrome | 22283845 | CNVD |
| Breast cancer | 16272173 | CNVD |
| Sotos syndrome | 20503325 | CNVD |
| Lung adenocarcinoma | 17086460 | CNVD |
| Congenital Hypertrichosis Syndrome | 21636067 | CNVD |
| T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
| Breast cancer | 19181860 | CNVD |
| Acute lymphoblastic leukemia | 21098271 | CNVD |
| Ehlers-danlos syndrome | 17576883 | CNVD |
| Lung cancer | 17086460 | CNVD |
| Autism | 19246517 | CNVD |
| Basal cell lymphoma | 19029149 | CNVD |
| Diffuse large b-cell lymphoma | 19029149 | CNVD |
| Melanoma | 20877625 | CNVD |
| Breast cancer | 22522925 | CNVD |
| Pancreatic cancer | 17952125 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr5:179052200-179085400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
| 2 | chr5:179070800-179078000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
| 3 | chr5:179075400-179075800 | Enhancers | Fetal Muscle Leg | muscle |
| 4 | chr5:179075400-179076800 | Enhancers | Fetal Muscle Trunk | muscle |
| 5 | chr5:179076200-179076600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
| 6 | chr5:179076200-179076800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
| 7 | chr5:179076400-179076600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
| 8 | chr5:179078000-179078200 | Flanking Bivalent TSS/Enh | Foreskin Fibroblast Primary Cells skin02 | Skin |
| 9 | chr5:179078000-179078400 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
| 10 | chr5:179078000-179078400 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
| 11 | chr5:179078200-179078400 | Bivalent/Poised TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
| 12 | chr5:179078200-179085400 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |






